CSF2 and neoplasm: Recent studies have explored the conditional immune-regulatory gene expression system, which enables tumor-specific viruses (OVs) to specifically release immune-regulatory molecules (e.g., IL-12 and GM-CSF) in the tumor-specific microenvironment, thereby promoting local immune activation while reducing the risk of systemic inflammation [152,153].